Bluegrass Vascular Closes $5M in Convertible Debt Financing
Bluegrass Vascular Technologies has closed $5 million in convertible debt financing for its innovation, the Surfacer Inside-Out Access Catheter System. Convertible debt notes enable a startup without a valuation to raise capital quickly and less expensively than equity as an alternative to a... Read More →
Singleron Acquires Proteona
Singleron further extends reach outside China and strengthens its expertise in translational and clinical research NANJING/SUZHOU, China and COLOGNE, Germany and SINGAPORE, March 7, 2022 /PRNewswire/ — Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform... Read More →
Fierce Medtech Names Tasso as One of Its “Fierce 15” Med Tech Companies of 2021
SEATTLE–(BUSINESS WIRE)–Tasso, Inc., a leader in clinical-grade blood collection technology, today announced that it has been named by Fierce Medtech as one of 2021’s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies... Read More →
Venari Medical announces publication of pre-clinical data in leading scientific journal Phlebology and changes name to InVera Medical™
InVera Medical™ (formerly known as Venari Medical) are delighted to announce the publication of its pre-clinical feasibility study of the InVera™ minimally invasive, exclusively mechanical venous ablation device in Phlebology, an official journal of several international venous societies. The study... Read More →
MindMaze to advance digital neurotherapeutics with $105-million raise
MindMaze announced Thursday that it secured a $105-million financing round to accelerate its global growth plans, support ongoing R&D and consolidate the clinical development pipeline of its digital therapeutic solutions for neurological diseases. “This funding allows us to ramp up commercial activity... Read More →
Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System
FDA-Cleared REMI Platform to Begin Initial Commercialization to Hospitals for Use in Emergency Departments and Intensive Care Units Across the United States Epitel introduces REMI, a wearable, wireless EEG monitoring platform for seizure detection. Epitel’s first FDA-cleared product can be... Read More →
Orthox Closes $12.5m Series A Financing for Clinical Trials of Knee Cartilage Repair FibroFix™ Product Platform
Oxford, UK – 9th February 2022 – Orthox Limited, a clinical stage company developing medical implants to repair damaged knee articular cartilage and other orthopaedic injuries, announces the completion of a further $4.3m (£3.2m) to close its $12.5m (£9.2m) Series... Read More →
Day Zero Diagnostics Announces Completion of $21M Financing
BOSTON – February 9, 2022 – Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to combat the rise of antibiotic-resistant infections, announced the completion of a $21M venture equity financing. The round... Read More →
Koya Medical secures US$26 million in Series B funding to advance portfolio of active compression therapies for lymphoedema and venous disorders
Koya Medical has announced the close of a US$26 million Series B financing. The round was led by 3×5 Partners, along with new investors including Asahi Kasei Ventures, Cadence Healthcare Ventures, and existing investors Arboretum Ventures and Scientific Health Development,... Read More →
CroíValve Raises an €8M Series A Round to Support a Feasibility Clinical Study Expands the Board of Directors and Leadership Team
CroíValve, a Dublin based medical device company developing a novel treatment for tricuspid regurgitation, has raised a Series A round to fund a Feasibility clinical study with its DUO Coaptation Valve system. This novel approach to treating tricuspid regurgitation combines... Read More →